Cargando…

Effects of Trilostane on urinary Catecholamines and their metabolites in dogs with Hypercortisolism

BACKGROUND: Glucocorticoids influence the synthesis and metabolism of catecholamines (epinephrine and norepinephrine) and metanephrines (metanephrine and normetanephrine). The aim of this study was to measure urinary catecholamines and metanephrines in dogs with hypercortisolism before and during tr...

Descripción completa

Detalles Bibliográficos
Autores principales:	Sieber-Ruckstuhl, Nadja, Salesov, Elena, Quante, Saskia, Riond, Barbara, Rentsch, Katharina, Hofmann-Lehmann, Regina, Reusch, Claudia, Boretti, Felicitas
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2017
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5583971/ https://www.ncbi.nlm.nih.gov/pubmed/28870207 http://dx.doi.org/10.1186/s12917-017-1187-0

Ejemplares similares

Comparison of two prepill cortisol concentrations in dogs with hypercortisolism treated with trilostane
por: Boretti, Felicitas, et al.
Publicado: (2018)

Urinary and Plasma Catecholamines and Metanephrines in Dogs with Pheochromocytoma, Hypercortisolism, Nonadrenal Disease and in Healthy Dogs
por: Salesov, E., et al.
Publicado: (2015)

Urinary Corticoid Concentrations Measured by 5 Different Immunoassays and Gas Chromatography‐Mass Spectrometry in Healthy Dogs and Dogs with Hypercortisolism at Home and in the Hospital
por: Galeandro, L., et al.
Publicado: (2014)

Comparison of methods to monitor dogs with hypercortisolism treated with trilostane
por: Golinelli, Stefania, et al.
Publicado: (2021)

Evaluation of the Cortisol‐to‐ACTH Ratio in Dogs with Hypoadrenocorticism, Dogs with Diseases Mimicking Hypoadrenocorticism and in Healthy Dogs
por: Boretti, F.S., et al.
Publicado: (2015)

Clinical features and long‐term management of cats with primary hypoadrenocorticism using desoxycorticosterone pivalate and prednisolone
por: Sieber‐Ruckstuhl, Nadja S., et al.
Publicado: (2023)

Effects of ACTH-Induced Long-Term Hypercortisolism on the Transcriptome of Canine Visceral Adipose Tissue
por: Tavares Pereira, Miguel, et al.
Publicado: (2022)

Pre-trilostane and three-hour post-trilostane cortisol to monitor trilostane therapy in dogs
por: Macfarlane, L., et al.
Publicado: (2016)

Salivary cortisol in healthy dogs: a randomized cross-over study to evaluate different saliva stimulation methods and their effects on saliva volume and cortisol concentration
por: Meunier, Solène, et al.
Publicado: (2021)

Cortisol Response in Healthy and Diseased Dogs after Stimulation with a Depot Formulation of Synthetic ACTH
por: Sieber‐Ruckstuhl, N.S., et al.
Publicado: (2015)

Evaluation of a low‐dose desoxycorticosterone pivalate treatment protocol for long‐term management of dogs with primary hypoadrenocorticism
por: Sieber‐Ruckstuhl, Nadia S., et al.
Publicado: (2019)

Use of Plasma Renin Activity to Monitor Mineralocorticoid Treatment in Dogs with Primary Hypoadrenocorticism: Desoxycorticosterone Versus Fludrocortisone
por: Baumstark, M.E., et al.
Publicado: (2014)

Altered Serum Thyrotropin Concentrations in Dogs with Primary Hypoadrenocorticism before and during Treatment
por: Reusch, C.E., et al.
Publicado: (2017)

Evaluation of Aldosterone Concentrations in Dogs with Hypoadrenocorticism
por: Baumstark, M.E., et al.
Publicado: (2013)

Serum lipidome analysis of healthy beagle dogs receiving different diets
por: Boretti, Felicitas S., et al.
Publicado: (2019)

Cortisol Concentrations in Well‐Regulated Dogs with Hyperadrenocorticism Treated with Trilostane
por: Midence, J.N., et al.
Publicado: (2015)

Laboratory assessment of trilostane treatment in dogs with pituitary‐dependent hyperadrenocorticism
por: Arenas Bermejo, Carolina, et al.
Publicado: (2020)

Successful treatment of occult hyperadrenocorticism with mitotane but not trilostane in a dog
por: Park, Su‐Min, et al.
Publicado: (2021)

Evaluation of compounded trilostane packets for dogs with naturally occurring hyperadrenocorticism
por: Nam, Sookin, et al.
Publicado: (2021)

Protection from reinfection in “Candidatus Mycoplasma turicensis”-infected cats and characterization of the immune response
por: Novacco, Marilisa, et al.
Publicado: (2012)

Characterization of recombinant human and bovine thyroid-stimulating hormone preparations by mass spectrometry and determination of their endotoxin content
por: Schaefer, Sandra, et al.
Publicado: (2013)

Serum Lipidome Signatures of Dogs with Different Endocrinopathies Associated with Hyperlipidemia
por: Sieber-Ruckstuhl, Nadja S., et al.
Publicado: (2022)

Antibody Response to Canine Parvovirus Vaccination in Dogs with Hyperadrenocorticism Treated with Trilostane
por: Bergmann, Michèle, et al.
Publicado: (2020)

Erratum for “Evaluation of compounded trilostane packets for dogs with naturally occurring hyperadrenocorticism”
Publicado: (2022)

Lack of cross-protection against Mycoplasma haemofelis infection and signs of enhancement in “Candidatus Mycoplasma turicensis”-recovered cats
por: Baumann, Julia, et al.
Publicado: (2015)

Effect of Trilostane and Mitotane on Aldosterone Secretory Reserve in Dogs with Pituitary‐Dependent Hyperadrenocorticism
por: Reid, L.E., et al.
Publicado: (2014)

Effect of Trilostane on Hormone and Serum Electrolyte Concentrations in Dogs with Pituitary‐Dependent Hyperadrenocorticism
por: Griebsch, C., et al.
Publicado: (2013)

In vivo transmission studies of ‘Candidatus Mycoplasma turicensis’ in the domestic cat
por: Museux, Kristina, et al.
Publicado: (2009)

Glycemic variability in newly diagnosed diabetic cats treated with the glucagon‐like peptide‐1 analogue exenatide extended release
por: Krämer, Anna L., et al.
Publicado: (2020)

Chronic "Candidatus Mycoplasma turicensis" infection
por: Novacco, Marilisa, et al.
Publicado: (2011)

Retroviral DNA—the silent winner: blood transfusion containing latent feline leukemia provirus causes infection and disease in naïve recipient cats
por: Nesina, Stefanie, et al.
Publicado: (2015)

The effect of 1 year of trilostane treatment on peripheral lymphocyte subsets in dogs with pituitary-dependent hyperadrenocorticism
por: ODA, Hitomi, et al.
Publicado: (2016)

Changes in systolic blood pressure in dogs with pituitary dependent hyperadrenocorticism during the first year of trilostane treatment
por: García San José, Paula, et al.
Publicado: (2020)

Serum Bile Acids Concentrations and Liver Enzyme Activities after Low-Dose Trilostane in Dogs with Hyperadrenocorticism
por: Tinted, Nannicha, et al.
Publicado: (2023)

Clinical, serological and echocardiographic examination of healthy field dogs before and after vaccination with a commercial tetravalent leptospirosis vaccine
por: Spiri, Andrea M., et al.
Publicado: (2017)

Modified-Live Feline Calicivirus Vaccination Reduces Viral RNA Loads, Duration of RNAemia, and the Severity of Clinical Signs after Heterologous Feline Calicivirus Challenge
por: Spiri, Andrea M., et al.
Publicado: (2021)

Possible Therapeutic Effect of Trilostane in Rodent Models of Inflammation and Nociception()
por: Tung, David, et al.
Publicado: (2013)

Adrenal steroid metabolites and bone status in patients with adrenal incidentalomas and hypercortisolism
por: Nakao, Hiroshi, et al.
Publicado: (2023)

TRH-induced secretion of adrenocorticotropin and cortisol in dogs with pituitary-dependent hypercortisolism
por: Pijnacker, Tera, et al.
Publicado: (2018)

Calcium and phosphate homeostasis in dogs with newly diagnosed naturally occurring hypercortisolism
por: Corsini, Andrea, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_rthlteuc9cghln1f52avg30tbp